30.03.2021
AiCuris expands its Management with Prof. Dr. Hubert Trübel joining as Chief Medical Officer and the Appointment of Dr. Tamara Pfaff, Head of Preclinical Development, to the Management Team
Prof. Hubert Trübel joined AiCuris as Head of Clinical Development and Chief Medical Officer. In addition, the Head of Preclinical Development, Dr. Tamara Pfaff, was also appointed to the management team effective April 1, 2021
more ...
18.03.2021
Meet us at BIO-Europe® Spring Digital 2021
AiCuris will be present throughout the BIO-Europe® Spring Digital 2021 partnering conference.
more ...
01.02.2021
AiCuris changes its legal form: AiCuris Anti-infective Cures GmbH becomes AiCuris AG
Transition will support the Company in exploring additional opportunities for future growth
more ...
13.01.2021
AiCuris selects three novel anti-infective treatment approaches as winners of the AiCubator Resident Status, a corporate innovative accelerator initiative
AiCuris selects three novel anti-infective treatment approaches as winners of the AiCubator Resident Status, a corporate innovative accelerator initiative
more ...
08.01.2021
AiCuris to Present at the 39th Annual J.P. Morgan Healthcare Conference
AiCuris to Present at the 39th Annual J.P. Morgan Healthcare Conference
more ...
